⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 32 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 1 hour ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 32 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 1 hour ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT June 11, 2026

Diamicron MR 30 mg Tabletten mit veränderter Wirkstofffreisetzung 30 mg (Tablette mit veränderter Wirkstofffreisetzung)

📷 Wikipedia: Gliclazide · Source
Diamicron MR 30 mg Tabletten mit veränderter Wirkstofffreisetzung 30 mg (Tablette mit veränderter Wirkstofffreisetzung)
📷 Wikipedia: Gliclazide · Source
Diamicron MR 30 mg modified-release tablets Parallel export ban in effect.
⚠️
Shortage ongoing
GLICLAZID is currently in short supply in AT.
📈 Timeline
91 days active so far
June 13, 2026 September 11, 2026

What is this? Diamicron MR is a medicine for diabetes. It helps control blood sugar.

What's happening? Some packs of this medicine are not available right now. They will be back in stock soon.

Does this affect me? If you take this medicine, you may need a different pack size for now.

What should I do? Ask your pharmacist or doctor for help before changing how you take your medicine.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
GLICLAZID
Agency-published detail

🚫 Parallel export ban active · ATC: A10BB09 · Reason: Erhöhter Mehrbedarf · Marketing authorisation holder: Servier Austria GmbH, Mariahilfer Straße 20/7, 1070 Wien, Österreich · Affected packs: 30 Stück Schachtel, Blisterpackung [eingeschränkt verfügbar, since 2026-06-11, resupply 2026-09-24] · 120 Stück Schachtel, Blisterpackung [verfügbar]

First published
June 11, 2026
Last refreshed by us
1 hour ago
Severity (as classified)
Medium
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

Low AT resolved 3 months ago

Gliclazid-ratiopharm 30 mg Tabletten mit veränderter Wirkstofffreisetzung 30 mg (Tablette mit veränderter Wirkstofffreisetzung)

Gliclazid-ratiopharm 30 mg modified-release tablets 30 mg (modified-release tablet) Reason: manufacturing delay Marketing authorisation holder: Teva B.V., Swensweg 5, 2031 GA Haarlem, Netherlands Aff...

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Diamicron MR 30 mg Tabletten mit veränderter Wirkstofffreisetzung 30 mg (Tablette mit veränderter Wirkstofffreisetzung). Diamicron MR 30 mg modified-release tablets Parallel export ban in effect.
▸ When was this alert issued?
This alert was issued on June 11, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Medium risk. A medium risk means harm is possible under certain conditions. Read the notice and act on the recommended steps.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.